More than 4,400 lawsuits have been filed since millions of Americans embraced GLP-1 drugs like Ozempic, Wegovy and Mounjaro to lose weight.
From opening new therapeutic mechanisms to repairing neuronal damage, investigational molecules from Ventyx Therapeutics, AC ...
Half of Canadians don’t truly understand their risk for stroke or heart attack, says a report from the Heart and Stroke ...
Discusses 2026 Clinical Pipeline Outlook and Anticipated Trial Updates February 2, 2026 7:01 PM ESTCompany ParticipantsGary ...
About VIVUS VIVUS is a biopharmaceutical company committed to the development and commercialization of innovative therapies that focus on advancing treatments for patients with serious unmet medical ...
Participants in the combined treatment group lost significantly more weight at 3, 6, and 12 months and were more likely to lose 5%, 10%, or >15% of their body weight at 12 months compared with DELI al ...
The Vaccine Injury Compensation Program was created in 1986 after a flood of vaccine injury lawsuits drove drugmakers from the market.
Statins do not cause the majority of the conditions that have been listed in their package leaflets, including memory loss, ...
Sleep apnea sufferers may soon have a new path to a good night’s sleep. A Massachusetts biotech startup is preparing to file for FDA approval of a once-nightly pill that could become the first ...
On Super Bowl Sunday, the drug industry is trotting out lounging football stars, a shouting DJ Khaled, and the soothing tones ...
The first antihistamine that the Food and Drug Administration approved was diphenhydramine. The compound was created in 1943, and the Parke-Davis pharmaceutical company brought it to market in 1946 ...
To eliminate bedtime struggles, a growing number of parents have turned to melatonin gummies, but these hormone supplements are largely unregulated. Columnist Alice Klein digs into the evidence on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results